Syremis Therapeutics Funding: $165M Raised, Series A (2025)
Syremis Therapeutics is based in Petah Tikva, Israel. It has raised $165M in total funding. Latest round: Series A.
Syremis Therapeutics funding overview
Syremis Therapeutics is based in Petah Tikva, Israel. Syremis Therapeutics has raised $165M in total disclosed funding. That places its disclosed total in the $100M–$250M range. Its most recent disclosed round is a Series A announced in December 2025. The round record for Syremis Therapeutics runs through 2025; nothing later has been disclosed. Investors on record include Dexcel Pharma, Third Rock Ventures, Bain Capital Life Sciences, GV (Google Ventures), QVT Financial LP, Pictet Group. 6 distinct backers are named across the disclosed rounds.
Syremis Therapeutics at a glance
Total raised
$165M
Latest round
Series A
Latest round date
December 2025
Headquarters
Petah Tikva, Israel
Notable investors
Dexcel Pharma, Third Rock Ventures, Bain Capital Life Sciences, GV (Google Ventures), QVT Financial LP, Pictet Group
Frequently asked about Syremis Therapeutics funding
How much has Syremis Therapeutics raised?
Syremis Therapeutics has raised $165M in total disclosed funding across the rounds on record.
Who has invested in Syremis Therapeutics?
Dexcel Pharma, Third Rock Ventures, Bain Capital Life Sciences, GV (Google Ventures), QVT Financial LP, Pictet Group are named among the investors backing Syremis Therapeutics.
What was the latest Syremis Therapeutics funding round?
The most recent disclosed round is a Series A, announced in December 2025.
Where is Syremis Therapeutics based?
Syremis Therapeutics is based in Petah Tikva, Israel.
When did Syremis Therapeutics last raise?
The last disclosed Syremis Therapeutics round closed in December 2025 at Series A.
We update the Syremis Therapeutics record whenever a new round is filed or announced, so the totals above track the public record rather than estimates. Related companies in Petah Tikva and their backers are listed below.
